Plasma Panel Patent Infringement Case Settles

Competitive Technologies, Inc. announced today that CTT, its client, the University of Illinois, and all Fujitsu defendants have reached a settlement in the long-standing patent infringement suit regarding US Patent Nos. 4,866,349 and 5,081,400 covering plasma display panels (PDPs) and related circuitry.

As part of the settlement, CTT will pay Fujitsu a minor portion of the approximately $233,000 costs awarded to Fujitsu by the courts in 2006. The parties will dismiss with prejudice all claims and counterclaims in the suit. As noted in CTT's Form 10-K for the fiscal year 2006, filed in October 2006, Fujitsu was seeking counterclaim damages estimated to be in excess of $5 million. CTT's settlement will eliminate any need for contingent payment to CTT's prior counsel in the International Trade Commission and District Court actions against Fujitsu.

"We came to an agreement with both our client, the University, and with Fujitsu, that all interests were best served by settling and thus terminating and concluding this long-running litigation," said John B. Nano, CTT's Chairman, President and CEO. "Our overall interests are upheld by considering the long-term benefit to our client, the University, and to CTT and our shareholders."

Mr. Nano continued, "CTT looks forward to moving on from this point. We have a strong, viable portfolio of technologies. CTT is actively marketing our nutraceutical ingredients technology, molecular memory devices, HB LED technology, bone biomaterial, cholesterol trapping/regeneration technology, and Lupus diagnostic and monitoring technology to drive revenue growth, improve profitability and create shareholder value."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.